バイオチップの世界市場：マイクロアレイおよびラボオンチップ

世界のバイオチップの市場規模は、2024年の161億米ドルから、2024年から2029年にかけてはCAGR 11.6%で推移し、2029年には278億米ドルに達すると推定されています。

バイオチップ機器およびソフトウェアの市場は、2024年の68億米ドルから、CAGR 11.3%で推移し、2029年には116億米ドルに達すると推定されています。マイクロ流体バイオチップ（ラボオンチップ）の市場は、2024年の25億米ドルから、CAGR 12.6%で推移し、2029年には46億米ドルに達すると推定されています。

当レポートでは、世界のバイオチップの市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析などをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場サマリー

第2章 市場概要

• 概要・市場の定義
• 技術的背景
• 技術インフラとデータ統合

第3章 市場力学

• 市場力学
• 市場促進要因
• ポイントオブケア診断の需要増加
• バイオチップとマイクロアレイの研究への投資と資金の増加
• がん罹患率の増加による個別化治療の需要の増加
• 市場抑制要因と課題
• バイオチップ技術の開発と導入に伴う高コスト
• 技術的課題
• 市場機会
• バイオチップ業界における技術の進歩と自動化
• 臨床研究の増加

第4章 規制状況

• 市場規制：機関別
• 米国
• 連邦規制
• CMS規制
• FDA規制
• FTC規制
• カナダ
• EU
• 英国
• 中国
• 日本
• オーストラリア
• 国際基準とガイドライン

第5章 新興技術と開発

• バイオ医療におけるバイオチップ技術へのAIの応用
• DNAおよびタンパク質マイクロアレイの進歩
• 3Dマイクロアレイとオルガノイドオンチップ
• ハイドロゲルベースのマイクロアレイ
• その他の種類の3Dマイクロアレイ

第6章 市場セグメンテーション分析

• 市場概要
• セグメンテーションの内訳
• 世界のバイオチップ市場：製品別
• マイクロアレイ（アレイベースバイオチップ）
• マイクロ流体バイオチップ（ラボオンチップ）
• バイオチップ機器およびソフトウェア
• バイオチップ消耗品およびキット
• 世界のバイオチップ市場：技術別
• マイクロアレイ技術
• マイクロ流体技術
• 世界のバイオチップ市場：用途別
• ゲノミクス
• プロテオミクス
• 病気の診断
• 医薬品の発見と開発
• 世界のバイオチップ市場：エンドユーザー別
• 学術研究機関
• バイオ医薬品企業
• 病院・診断センター
• 地理的内訳
• 世界のバイオチップ市場：地域別
• 市場規模と予測
• 北米
• 欧州
• アジア太平洋
• その他の地域

第7章 競合情報

• 業界構造
• 画期的技術と製品の発売
• 主要企業ランキング
• 企業が採用している主要戦略
• 提携・協力
• 新製品の発売
• 拡大と投資
• M&A

第8章 バイオチップ市場における持続可能性：ESGの観点

• ESG：イントロダクション
• バイオチップ市場におけるESGのパフォーマンス
• バイオチップ業界におけるESGの実践
• 環境パフォーマンス
• 社会的パフォーマンス
• ガバナンスパフォーマンス
• ESGリスク評価
• BCCによる総論

第9章 付録

• 調査手法
• 略語
• 企業プロファイル
• ABBOTT
• AGILENT TECHNOLOGIES INC.
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• F. HOFFMANN-LA ROCHE LTD.
• IBIOCHIPS
• ILLUMINA INC.
• LI-COR BIOTECH LLC.
• MICRONIT B.V.
• NUTCRACKER THERAPEUTICS INC.
• QIAGEN
• RANDOX LABORATORIES LTD.
• REVVITY
• STANDARD BIOTOOLS
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : Global Biochip Market, by Product Type, Through 2029
• Table 1 : Molecular Biology Technologies for Microarray Approaches
• Table 2 : Global Biochip Market, by Product, Through 2029
• Table 3 : Global Market for Microarrays , by Region, Through 2029($ Millions)
• Table 4 : Global Market for Microarrays (Array-Based Biochips), by Product, Through 2029
• Table 5 : Global Market for DNA Microarrays, by Region, Through 2029
• Table 6 : Commercially Available Protein Microarrays
• Table 7 : Global Market for Protein Microarrays, by Region, Through 2029
• Table 8 : Global Market for Peptide/Tissue/Other Specialty Microarrays, by Region, Through 2029
• Table 9 : Global Market for Microfluidic Biochips (Lab-on-a-Chip), by Region, Through 2029
• Table 10 : Global Market for Microfluidic Biochips (Lab-on-a-Chip), by Product, Through 2029
• Table 11 : Global Market for Microfluidic Chips, by Region, Through 2029
• Table 12 : Global Market for Organ-on-a-Chip, by Region, Through 2029
• Table 13 : Global Market for Biochip Equipment and Software, by Region, Through 2029
• Table 14 : Global Market for Biochip Equipment and Software, by Product, Through 2029
• Table 15 : Global Market for Biochip Sample Preparation Equipment, by Region, Through 2029
• Table 16 : Global Market for Biochip Array Processing Equipment, by Region, Through 2029
• Table 17 : Global Market for Biochip Scanners and Imaging Systems, by Region, Through 2029
• Table 18 : Global Market for Biochip Analysis Software, by Region, Through 2029
• Table 19 : Global Market for Biochip Consumables and Kits, by Region, Through 2029
• Table 20 : Global Market for Biochip Consumables and Kits, by Product, Through 2029
• Table 21 : Global Market for Microarray Kits and Reagents, by Region, Through 2029
• Table 22 : Global Market for Microfluidic Chip Kits, by Region, Through 2029
• Table 23 : Global Market for Biochip Sensors and Probes, by Region, Through 2029
• Table 24 : Global Market for Biochips, by Technology, Through 2029
• Table 25 : Global Biochip Market for Microarray Technology, by Region, Through 2029
• Table 26 : Global Biochip Market for Microfluidics Technology, by Region, Through 2029
• Table 27 : Global Biochip Market, by Application, Through 2029
• Table 28 : Global Biochip Market for Genomics, by Region, Through 2029
• Table 29 : Global Biochip Market for Proteomics, by Region, Through 2029
• Table 30 : Global Biochip Market for Disease Diagnostics, by Region, Through 2029
• Table 31 : Global Biochip Market for Drug Discovery and Development, by Region, Through 2029
• Table 32 : Global Biochip Market, by End User, Through 2029
• Table 33 : Global Biochip Market for Academic and Research Institutes, by Region, Through 2029
• Table 34 : Global Biochip Market for Biopharmaceutical Companies, by Region, Through 2029
• Table 35 : Global Biochip Market for Hospitals and Diagnostic Centers, by Region, Through 2029
• Table 36 : Global Biochip Market, by Region, Through 2029
• Table 37 : North American Biochip Market, by Country, Through 2029
• Table 38 : North American Biochip Market, by Product, Through 2029
• Table 39 : North American Biochip Market for Microarrays (Array-Based Biochips), by Product, Through 2029
• Table 40 : North American Biochip Market for Microfluidic Biochips (Lab-on-a-Chip), by Product, Through 2029
• Table 41 : North American Biochip Market for Equipment and Software, by Product, Through 2029
• Table 42 : North American Biochip Market for Consumables and Kits, by Product, Through 2029
• Table 43 : North American Biochip Market, by Technology, Through 2029
• Table 44 : North American Biochip Market, by Application, Through 2029
• Table 45 : North American Biochip Market, by End User, Through 2029
• Table 46 : European Biochip Market, by Country, Through 2029
• Table 47 : European Biochip Market, by Product, Through 2029
• Table 48 : European Biochip Market for Microarrays (Array-Based Biochips), by Product 2029
• Table 49 : European Biochip Market for Microfluidic Biochips (Lab-on-a-Chip), by Product, Through 2029
• Table 50 : European Biochip Market for Equipment and Software, by Product, Through 2029
• Table 51 : European Biochip Market for Consumables and Kits, by Product, Through 2029
• Table 52 : European Biochip Market, by Technology, Through 2029
• Table 53 : European Biochip Market, by Application, Through 2029
• Table 54 : European Biochip Market, by End User, Through 2029
• Table 55 : Asia-Pacific Biochip Market, by Country, Through 2029
• Table 56 : Asia-Pacific Biochip Market, by Product, Through 2029
• Table 57 : Asia-Pacific Biochip Market for Microarrays (Array-Based Biochips), by Product, Through 2029
• Table 58 : Asia-Pacific Biochip Market for Microfluidic Biochips (Lab-on-a-Chip), by Product, Through 2029
• Table 59 : Asia-Pacific Biochip Market for Equipment and Software, by Product,Through 2029
• Table 60 : Asia-Pacific Biochip Market for Consumables and Kits, by Product,Through 2029
• Table 61 : Asia-Pacific Biochip Market, by Technology, Through 2029
• Table 62 : Asia-Pacific Biochip Market, by Application, Through 2029
• Table 63 : Asia-Pacific Biochip Market, by End User, Through 2029
• Table 64 : ROW Biochip Market, by Product Type, Through 2029
• Table 65 : ROW Biochip Market, by Technology, Through 2029
• Table 66 : ROW Biochip Market, by Application, Through 2029
• Table 67 : ROW Biochip Market, by End User, Through 2029
• Table 68 : Top Companies in the Biochip Market, 2023
• Table 69 : Collaborations and Partnerships in the Biochip Market, 2021-2024
• Table 70 : Products Launches in the Biochip Market, 2021-2024
• Table 71 : Expansion and Investments in the Biochip Market, 2021-2024
• Table 72 : Mergers and Acquisitions in the Biochip Market, 2020-2024
• Table 73 : Key Focus Areas in ESG Metrics
• Table 74 : Environmental Performance Initiatives in the Biochip Market
• Table 75 : Social Performance Initiatives in the Biochip Market
• Table 76 : Governance Performance Initiatives in the Biochip Market
• Table 77 : ESG Rankings for Biochip Companies, 2024*
• Table 78 : Abbreviations Used in this Report
• Table 79 : Abbott: Company Snapshot
• Table 80 : Abbott: Financial Performance, FY 2023 and 2024
• Table 81 : Abbott: Product Portfolio
• Table 82 : Abbott: News/Key Developments, 2023 and 2024
• Table 83 : Agilent Technologies Inc.: Company Snapshot
• Table 84 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
• Table 85 : Agilent Technologies Inc.: Product Portfolio
• Table 86 : Agilent Technologies Inc.: News/Key Developments, 2023
• Table 87 : BioMerieux: Company Snapshot
• Table 88 : BioMerieux: Financial Performance, FY 2022 and 2023
• Table 89 : BioMerieux: Product Portfolio
• Table 90 : BioMerieux: News/Key Developments, 2024 and 2025
• Table 91 : Bio-Rad Laboratories Inc.: Company Snapshot
• Table 92 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
• Table 93 : Bio-Rad Laboratories Inc.: Product Portfolio
• Table 94 : F. Hoffmann-La Roche Ltd.: Company Snapshot
• Table 95 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2023 and 2024
• Table 96 : F. Hoffman-La Roche Ltd.: Product Portfolio
• Table 97 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2024 and 2025
• Table 98 : iBioChips: Company Snapshot
• Table 99 : iBioChips: Product Portfolio
• Table 100 : Illumina Inc.: Company Snapshot
• Table 101 : Illumina Inc.: Financial Performance, FY 2023 and 2024
• Table 102 : Illumina Inc.: Product Portfolio
• Table 103 : Illumina Inc.: News/Key Developments, 2023 and 2024
• Table 104 : LI-COR Biotech LLC.: Company Snapshot
• Table 105 : LI-COR Biotech LLC.: Product Portfolio
• Table 106 : LI-COR Biotech LLC.: News/Key Developments, 2023 and 2024
• Table 107 : Micronit B.V.: Company Snapshot
• Table 108 : Micronit B.V.: Product Portfolio
• Table 109 : Micronit B.V.: News/Key Developments, 2023
• Table 110 : Nutcracker Therapeutics Inc.: Company Snapshot
• Table 111 : Nutcracker Therapeutics Inc.: Product Portfolio
• Table 112 : Nutcracker Therapeutics Inc.: News/Key Developments, 2022
• Table 113 : Qiagen: Company Snapshot
• Table 114 : Qiagen: Financial Performance, FY 2023 and 2024
• Table 115 : Qiagen: Product Portfolio
• Table 116 : Qiagen: News/Key Developments, 2023 and 2025
• Table 117 : Randox Laboratories Ltd.: Company Snapshot
• Table 118 : Randox Laboratories Ltd.: Product Portfolio
• Table 119 : Randox Laboratories Ltd.: News/Key Developments, 2025
• Table 120 : Revvity: Company Snapshot
• Table 121 : Revvity: Financial Performance, FY 2023 and 2024
• Table 122 : Revvity: Product Portfolio
• Table 123 : Revvity: News/Key Developments, 2024 and 2025
• Table 124 : Standard BioTools: Company Snapshot
• Table 125 : Standard BioTools: Financial Performance, FY 2023 and 2024
• Table 126 : Standard BioTools: Product Portfolio
• Table 127 : Standard BioTools: News/Key Developments, 2022 and 2023
• Table 128 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 129 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
• Table 130 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 131 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2024

List of Figures

• Summary Figure : Global Shares of Biochip Market, by Product Type, 2023
• Figure 1 : Market Dynamics of Global Biochip
• Figure 2 : Global Shares of Biochip Market, by Product, 2023
• Figure 3 : Global Shares of Biochip Market, by Technology, 2023
• Figure 4 : Global Shares of Biochip Market, by Application, 2023
• Figure 5 : Global Shares of Biochip Market, by End User, 2023
• Figure 6 : Global Shares of Biochip Market, by Region, 2023
• Figure 7 : North American Shares of Biochip Market, by Country, 2023
• Figure 8 : European Shares of Biochip Market, by Country, 2023
• Figure 9 : Asia-Pacific Shares of Biochip Market, by Country, 2023
• Figure 10 : Snapshot of ESG Pillars
• Figure 11 : Advantages of ESG for Companies
• Figure 12 : Shares of Biotech Companies Providing ESG Disclosure, 2022
• Figure 13 : Shares of ESG Disclosure Location of Biotech Companies, 2022
• Figure 14 : ABBOTT: Revenue Share, by Business Unit, FY 2024
• Figure 15 : ABBOTT: Revenue Share, by Country/Region, FY 2024
• Figure 16 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 17 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
• Figure 18 : BioMerieux: Revenue Share, by Business Unit, FY 2023
• Figure 19 : BioMerieux: Revenue Share, by Country/Region, FY 2023
• Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 21 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024
• Figure 22 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
• Figure 23 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
• Figure 24 : Illumina Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 25 : Illumina Inc.: Revenue Share, by Country/Region, FY 2024
• Figure 26 : QIAGEN: Revenue Share, by Business Unit, FY 2024
• Figure 27 : QIAGEN: Revenue Share, by Country/Region, FY 2024
• Figure 28 : REVVITY: Revenue Share, by Business Unit, FY 2024
• Figure 29 : REVVITY: Revenue Share, by Country/Region, FY 2024
• Figure 30 : Standard BioTools: Revenue Share, by Business Unit, FY 2024
• Figure 31 : Standard BioTools: Revenue Share, by Country/Region, FY 2024
• Figure 32 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 33 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

The biochip equipment and software market for biochip was valued at $6.8 billion in 2024 and is estimated to reach $11.6 billion by 2029, at a CAGR of 11.3% from 2024 through 2029.

The microfluidic biochips (lab-on-a-chip) market for biochip was valued at $2.5 billion in 2024 and is estimated to reach $4.6 billion by 2029, at a CAGR of 12.6% from 2024 through 2029.

Report Scope

This report provides an overview of the global biochip market and analyzes market trends. The report includes global revenue ($ million) for the base year 2023 and estimated data for the forecast period 2024 through 2029. The market is segmented based on product type, technology, application, end user industry and region. The regions covered in this study include North America, Europe, Asia-Pacific and Rest of the World (South America, the Middle East and Africa), focusing on major countries in these regions.

The report focuses on the significant trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking and shares of key companies in the global biochip market. There is also a dedicated section on company profiles that provides details about leading companies in the market.

The company profiles offer detailed information about business segments, financials, product portfolios and recent developments. By geographical region, the market has been segregated into North America, Europe, Asia-Pacific and the Rest of World, which includes the Middle East, Africa and South America. The North American region covers the U.S., Canada and Mexico. Europe examines Germany, the U.K., Italy, France, Spain and the Rest of Europe. Asia-Pacific encompasses China, Japan, India, Australia, South Korea and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, with estimates for 2024 and a forecast for 2025 through 2029.

Report Includes

• 76 data tables and 56 additional tables
• An analysis of the current and future global markets for biochip diagnostic products and technologies
• Analyses of global market trends, with historic revenue data from 2021 to 2024, and projected CAGRs through 2029
• Estimates of the size of and revenue prospects for the global biochip market, along with a market share analysis by product type, technology, application, end-user vertical, and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macro-economic factors
• A look at the major commercial biochip products and the future potential of each key market segment, emerging technologies, clinical trials, and other new developments
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading biotech companies
• Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity, venture fundings and investment outlook
• Company profiles of major players within the industry, including Abbott, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and BioMerieux

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview and Market Definition
• Technology Background
• Technological Infrastructure and Data Integration

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Demand for Point-of-Care Diagnostics
• Increasing Investment and Funding in Biochip and Microarray Research Activities
• Increasing Prevalence of Cancer Generating Demand for Personalized Treatments
• Market Restraints and Challenges
• High Costs Associated with Developing and Implementing Biochip Technology
• Technical Challenges
• Market Opportunities
• Technological Advances and Automation in the Biochip industry
• Growing Volume of Clinical Research

Chapter 4 Regulatory Landscape

• Market Regulations by Agency
• The U.S.
• Federal Regulation
• CMS Regulation
• FDA Regulation
• FTC Regulation
• Canada
• European Union
• The U.K.
• China
• Japan
• Australia
• International Standards and Guidelines

Chapter 5 Emerging Technologies and Developments

• Artificial Intelligence in Biochip Technology for Biomedicine
• Advances in DNA and Protein Microarrays
• 3D Microarrays and Organoid-on-a-Chip
• Hydrogel-Based Microarrays
• Other Types of 3D Microarrays

Chapter 6 Market Segmentation Analysis

• Market Overview
• Segmentation Breakdown
• Global Biochip Market by Product
• Microarrays (Array-Based Biochips)
• Microfluidic Biochips (Lab-on-a-Chip)
• Biochip Equipment and Software
• Biochip Consumables and Kits
• Global Biochip Market by Technology
• Microarray Technology
• Microfluidics Technology
• Global Biochip Market by Application
• Genomics
• Proteomics
• Disease Diagnostics
• Drug Discovery and Development
• Global Biochip Market by End User
• Academic and Research Institutes
• Biopharmaceutical Companies
• Hospitals and Diagnostic Centers
• Geographic Breakdown
• Global Biochip Market by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of World (ROW)

Chapter 7 Competitive Intelligence

• Industry Structure
• Breakthrough Technologies and Product Launches
• Top Company Rankings
• Key Strategies Adopted by Companies
• Collaborations and Partnerships
• New Product Launch
• Expansion and Investment
• Mergers and Acquisitions

Chapter 8 Sustainability in the Biochip Market: An ESG Perspective

• Introduction to ESG
• ESG Performance in the Biochip Market
• ESG Practices in the Biochip Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Methodology
• Abbreviations
• Company Profiles
• ABBOTT
• AGILENT TECHNOLOGIES INC.
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• F. HOFFMANN-LA ROCHE LTD.
• IBIOCHIPS
• ILLUMINA INC.
• LI-COR BIOTECH LLC.
• MICRONIT B.V.
• NUTCRACKER THERAPEUTICS INC.
• QIAGEN
• RANDOX LABORATORIES LTD.
• REVVITY
• STANDARD BIOTOOLS
• THERMO FISHER SCIENTIFIC INC.